Geiger Counter Limited Plc 

Monthly Investor Report 22 October 2025

(All Factsheet data is at 31 September 2025)

The full monthly factsheet is now available on the Company's website and a summary can be found below. 

NCIM - Geiger Counter Ltd - Fund Page for Geiger Counter Ltd

Enquiries: 

For the Investment Manager 

Craig Cleland 

Manulife CQS Investment Management

0207 201 5368 

For the Company Secretary and Administrator 

Summit Fund Services Jersey Limited

Christopher Foulds/Katie De La Cour

01534 825219/01534 825337 

----------------------------------------------------------------------- 

Fund Description 

The objective of Geiger Counter Limited is to provide investors with the potential for capital growth through investment primarily in the securities of companies involved in the exploration, development and production of energy, predominantly within the uranium industry. Up to 30% of the value of the Company's investment portfolio may be invested in other resource- related companies from outside the energy sector.

Portfolio Managers 

Keith Watson and Robert Crayfourd 

Key Advantages for the Investor 

·      Access to mining assets in the uranium sector

·      May benefit from embedded subscription share

·      Low correlation to major asset classes

Key Fund Facts¹ 

Ordinary Share and NAV Performance² 

Commentary³ 

The fund NAV gained 20.1% over the month.

The World Nuclear Association (WNA) conference in London took place in September, with the bulk of the worlds uranium producers and utilities requiring supply. This saw a broad positive outlook for the sectors outlook against the backdrop of increased demand for Nuclear to supply power to data centres for AI. We note the fundamentals pointed to tight markets before the incremental addition of demand from big tech. Microsoft were a notable attendee, highlighting the importance of Nuclear in future power demand needs. The latest bi-annual supply/demand report from the WNA highlighted that demand is expected to jump by 28% in the next five years and double by 2040, with current and projected uranium mined supply insufficient to meet that demand. We note this data was produced as at 30th of June and does not include production downgrades from Cameco, Kazatomprom and Paladin, nor does it include incremental positive views on SMR's for data centres post that period.

Whilst spot price gets all the attention the majority of U3O8 is sold via term contracts. The Term price lifted to $83/lb this month having stayed around $79/lb for the prior year. Q4 is seasonally a stronger period for utility contracting and with a mixture of life extensions and advancing plans for SMR's there looks an increasing incentive for stronger contracting given low utility inventories in the west, with just 14 months in the US.

The Sprott Physical Uranium Trust (SPUT) returned to a premium, allowing it to issue equity and return to buying physical Uranium. This has been a material driver of tightening supply/demand fundamentals.

Nexgen will have its first hearing re its federal permit on the 19th of November, with the second

hearing scheduled for February 9th to 13th 2026. They have already received their provincial

permit.

CQS (UK) LLP

4th Floor, One Strand, London WC2N 5HR, United Kingdom

T: +44 (0) 20 7201 6900 | F: +44 (0) 20 7201 1200

CQS (US), LLC

152 West 57th Street, 40th Floor, New York, NY 10019, US

T: +1 212 259 2900 | F: +1 212 259 2699

Tavistock Communications

18 St. Swithin's Lane, London EC4N 8AD

T: +44 20 7920 3150 | [email protected]

Sources: ¹Summit Fund Services Jersey Limited, as at the last business day of the month indicated at the top of this report. ²Summit Fund Services Jersey Limited /DataStream, as at the last business day of the month indicated at the top of this report, total return performance net of fees and expenses based on bid prices. These include historic returns and past performance is not a reliable indicator of future results. The value of investments can go down as well as up. Please read the important legal notice at the end of this document. ³Market data sourced from Bloomberg unless otherwise stated. The Fund may since have exited some or all of the positions detailed in the commentary. ⁴ BMO, UxC, Company data September 2023. ⁵ www.eia.gov. ⁶CQS, as at the last business day of the month indicated at the top of this report. For methodology details see Article 4(3) of Directive 2011/61/EU (AIFMD) and Articles 6, 7, 9 and 10 of Delegated Regulation 231/2013. ⁷CQS, as at the last business day of the month indicated at the top of this report. For methodology details see Article 4(3) of Directive 2011/61/EU (AIFMD) and Articles 6, 8, 9, 10 and 11 of Delegated Regulation 3231/2013.

The Company has announced the fifth Subscription Rights Price of 32.70 pence on 1 May 2025. The exercise date for the fifth Subscription Right is expected to be 30 April 2026.